NASDAQ:EVAX - Nasdaq - US29970R3030 - ADR - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 3.29M | 3.34M | 73.00K | 0.00 | 0.00 | |||
Operating Expenses | 17.50M | 18.08M | 22.27M | 25.26M | 25.83M | |||
Research and Development | 9.78M | 10.15M | 11.58M | 17.04M | 19.61M | |||
Selling, General, and Administrative Expenses | 7.72M | 7.32M | 10.08M | 8.07M | 6.18M | |||
Operating Income | -14.20M | -14.73M | -22.20M | -25.26M | -25.83M | |||
Interest Income/Expense | 86.00K | 3.31M | -718.00K | 1.32M | 1.12M | |||
Other Income/Expense | N/A | 65.00K | N/A | N/A | N/A | |||
Income Before Taxes | -14.10M | -11.36M | -22.91M | -23.94M | -24.71M | |||
Income Tax | -762.00K | -788.00K | -790.00K | -772.00K | -178.00K | |||
Net Income | -13.34M | -10.57M | -22.13M | -23.17M | -24.53M | |||
EBITDA | N/A | -14.13M | -21.58M | -24.69M | -25.49M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -9.42 | -8.62 | -353.97 | -428.69 | -550.47 | |||
Non GAAP EPS | -1.37 | 0.63 | -41.00 | -49.00 | -62.50 | |||
Statistics | ||||||||
Profit Margin | -405.16% | -316.00% | -30308.22% | N/A | N/A | |||
Operating Profit Margin | -431.34% | -440.55% | -30406.85% | N/A | N/A |
All data in USD